000 01222 a2200385 4500
005 20250512020819.0
264 0 _c19891114
008 198911s 0 0 eng d
022 _a0031-7012
024 7 _a10.1159/000138581
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAbernethy, D R
245 0 0 _aOral 5-fluorouracil in psoriasis: pharmacokinetic-pharmacodynamic relationships.
_h[electronic resource]
260 _bPharmacology
_c1989
300 _a78-88 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aAdministration, Oral
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aDrug Resistance
650 0 4 _aFemale
650 0 4 _aFluorouracil
_xadministration & dosage
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aPsoriasis
_xdrug therapy
650 0 4 _aSpectrophotometry, Ultraviolet
700 1 _aAlper, J C
700 1 _aWiemann, M C
700 1 _aMcDonald, C J
700 1 _aCalabresi, P
773 0 _tPharmacology
_gvol. 39
_gno. 2
_gp. 78-88
856 4 0 _uhttps://doi.org/10.1159/000138581
_zAvailable from publisher's website
999 _c2804419
_d2804419